Home » Topics » BioWorld Science

BioWorld Science
RSS

New slective estrogen receptor degraders identified at Anlin Pharmaceuticals

June 5, 2019

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery patent anti-HBV compounds

June 5, 2019

Bayer and The Broad Institute synthesize Mcl-1 inhibitors

June 5, 2019

Arcutis begins phase IIa trial of ARQ-151 in atopic dermatitis

June 5, 2019

Merck & Co. describes new PRMT5 inhibitors

June 5, 2019

CDX-3379 plus cetuximab shows clinical activity in patients with HNSCC

June 5, 2019

Phase I study confirms Apexian Pharmaceuticals' APX-3330 mediates APE-1 activity

June 5, 2019

First-in-human results presented for ABBV-621

June 5, 2019

iPPS shows promising safety and efficacy in phase IIa study in chronic RRV-induced arthralgia

June 5, 2019

First patient dosed in B-SIMPLE phase III program of SB-206

June 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...